Elsevier

Neuropharmacology

Volume 30, Issue 11, November 1991, Pages 1193-1200
Neuropharmacology

Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion

https://doi.org/10.1016/0028-3908(91)90165-8Get rights and content

Abstract

Vasoactive neuropeptides, present in unmyelinated C-fibers, can be released from perivascular sensory axons by antidromic stimulation, to mediate vasodilation and extravasation of plasma protein (neurogenic inflammation). In this report, the effects of antidromic trigeminal stimulation on levels of calcitonin gene-related peptide (CGRP) in plasma were examined in the superior sagittal sinus and the effects of drugs that have been shown previously to block extravasation of neurogenic plasma determined. The levels of immunoreactive CGRP in plasma were measured both before and during electrical stimulation of the trigeminal ganglion (0.1–1.0 mA, 5 msec, 5 Hz, 3–5 min), using a highly specific and sensitive immunochemiluminometric assay. Levels of CGRP increased and became maximal within the first minute of stimulation. The increases were detectable at intensities of current as small as 0.1 mA. Peak levels related to the intensity of the stimulus. Samples from femoral arterial blood did not show concomitant increases at 1 min. Pretreatment with dihydroergotamine (DHE) (50 μg/kg i.v.) did not change the baseline levels but decreased levels of CGRP during stimulation (0.3 mA), by 55% at 1 min and 50% at 3 min. Sumatriptan (GR43175) (300 μg/kg) attenuated the increase by 57% at 3 min (0.1 mA, 5 msec, 5 Hz) but not after 1 min of stimulation, although decreases were observed at the latter time during an individual experiment. Drug-induced attenuation of levels of CGRP in plasma may reflect inhibition of release, to thereby provide evidence to explain blockade of neurogenic extravasation of plasma.

References (36)

  • S.D. Brain et al.

    Calcitonin gene-related peptide is a potent vasodilator

    Nature

    (1985)
  • M.G. Buzzi et al.

    The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

    Br. J. Pharmac.

    (1990)
  • M.G. Buzzi et al.

    Further characterization of the 5-HT1 receptor mediating blockade of neurogenic plasma extravasation within dura mater

    Br. J. Pharmac.

    (1991)
  • J. Byer et al.

    Dose-response study for subcutaneous GR43175 in the treatment of acute migraine

    Cephalalgia

    (1989)
  • W.B. Carter et al.

    Plasma calcitonin gene-related peptide concentrations by a new immunochemiluminometric assay in normal persons, and patients with medullary thyroid carcinoma and other neuroendocrine tumors

    J. clin. Endocrinol. Metab.

    (1991)
  • V. Dimitriadou et al.

    Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cells

    Neuroscience.

    (1991)
  • F.M. Faraci et al.

    Vascular responses of dura mater

    Am. J. Physiol.

    (1989)
  • W. Feniuk et al.

    The selective carotid arterial vasoconstrictor action of GR43175 in anesthetised dogs

    Br. J. Pharmac.

    (1989)
  • Cited by (297)

    • Headache

      2022, Comprehensive Pharmacology
    • Animal models of pain: Diversity and benefits

      2021, Journal of Neuroscience Methods
    View all citing articles on Scopus
    View full text